Katie Gaynor

Katie Gaynor is a highly experienced Principal Scientist and Team Leader at Bicycle Therapeutics, with a focus on biotherapeutics and antibody engineering since February 2019. Prior to this role, Katie served as a Senior Scientist in BioMedicine Design at Pfizer, leading portfolio projects aimed at developing biotherapeutic antibodies for cancer treatment. Earlier experience includes a lecturer and postdoctoral research fellow position at University College Dublin, where Katie conducted research on phage display technology and fibrotic lung diseases and contributed to academic support initiatives. Additional roles include research associate at Green Templeton College, postdoctoral research scientist at University of Oxford, and summer student at the Medical Research Council. Katie's educational foundation includes a Ph.D. in Clinical Medicine and an MBiochem in Molecular and Cellular Biochemistry from the University of Oxford.